The global Hepatitis Testing Market worth $3.6 billion by 2026, growing at a CAGR of 4.7% in the upcoming years. The growth of the global market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis. High cost of nucleic acid tests, lack of mandates for nucleic...